Dae-Sung Kim
Director/Miembro de la Junta en Great Orient Chemical Pte Ltd. .
Perfil
Dae-Sung Kim is currently a Director at Great Orient Chemical Pte Ltd.
and an Auditor at ID Biochem, Inc. He was previously the Chief Executive Officer & Director at ISU Abxis Co., Ltd.
from 2014 to 2017, Director, Executive Director & Director-Finance at ISU CHEMICAL CO., LTD.
from 2011 to 2012, and Director & Vice President at ISU Petasys Co., Ltd.
He obtained an undergraduate degree from Seoul National University.
Cargos activos de Dae-Sung Kim
| Empresas | Cargo | Inicio |
|---|---|---|
ID Biochem, Inc.
 ID Biochem, Inc. Chemicals: SpecialtyProcess Industries Part of Pharmicell Co., Ltd., ID Biochem, Inc. is a South Korean company based in Ulsan, South Korea. The company specializes in the production of pharmaceuticals, including vaccines, anti-cancer drugs, and stem cell therapies. In 2012, ID Biochem was acquired by Pharmicell Co., Ltd. for $19.28 million. | Comptroller/Controller/Auditor | - |
| Great Orient Chemical Pte Ltd. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Dae-Sung Kim.
| Empresas | Cargo | Fin |
|---|---|---|
| ISU ABXIS CO., LTD. | Director Ejecutivo | 24/03/2017 |
| ISU PETASYS CO., LTD. | Director/Miembro de la Junta | - |
| ISU CHEMICAL CO., LTD | Director Financiero/CFO | - |
Formación de Dae-Sung Kim.
| Seoul National University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ISU CHEMICAL CO., LTD | Process Industries |
| ISU ABXIS CO., LTD. | Health Technology |
| ISU PETASYS CO., LTD. | Electronic Technology |
| Empresas privadas | 2 |
|---|---|
ID Biochem, Inc.
ID Biochem, Inc. Chemicals: SpecialtyProcess Industries Part of Pharmicell Co., Ltd., ID Biochem, Inc. is a South Korean company based in Ulsan, South Korea. The company specializes in the production of pharmaceuticals, including vaccines, anti-cancer drugs, and stem cell therapies. In 2012, ID Biochem was acquired by Pharmicell Co., Ltd. for $19.28 million. | Process Industries |
| Great Orient Chemical Pte Ltd. |
- Bolsa de valores
- Insiders
- Dae-Sung Kim
